1. The future of immune checkpoint therapy;Sharma;Science,2015
2. New strategies in breast cancer: immunotherapy;Pusztai;Clin Cancer Res,2016
3. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs;Bianchini;Nat Rev Clin Oncol,2022
4. Role of immunotherapy in breast cancer;Jacob;JCO Oncology Practice,2023
5. Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Hegg R, Im SA, Shaw Wright G, Henschel V, Molinero L, Chui SY, Funke R, Husain A, Winer EP, Loi S, Emens LA; IMpassion130 Trial Investigators. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. N Engl J Med. 2018 Nov 29;379(22):2108-2121. doi: 10.1056/NEJMoa1809615. Epub 2018 Oct 20. PMID: 30345906.